Verici Dx plc (LON:VRCI – Get Free Report) shares traded down 0.3% on Thursday . The company traded as low as GBX 0.25 and last traded at GBX 0.30. 3,757,420 shares changed hands during trading, an increase of 116% from the average daily volume of 1,736,594 shares. The stock had previously closed at GBX 0.30.
Verici Dx Trading Down 0.3%
The business has a 50 day moving average of GBX 0.37 and a 200-day moving average of GBX 0.50. The stock has a market cap of £8.96 million, a PE ratio of -0.33 and a beta of 1.26. The company has a current ratio of 3.94, a quick ratio of 8.49 and a debt-to-equity ratio of 3.03.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Further Reading
- Five stocks we like better than Verici Dx
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
- Tesla: After a Rough Quarter, 2 Very Different Futures Come Into Focus
- Why NXP Semiconductors Could Be the AI Stock Everyone Is Missing
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
